The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.

about

The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.

Item

http://www.wikidata.org/entity/Q39448012

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.

@en

The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.

@nl

type

Item

label

The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.

@en

The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.

@nl

prefLabel

The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.

@en

The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.

@nl

P1476

The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.

@en

P2093

Anja Rinke

http://www.w3.org/2001/XMLSchema#string

Patrick Michl

http://www.w3.org/2001/XMLSchema#string

Sebastian Krug

http://www.w3.org/2001/XMLSchema#string

P2860

Lanreotide in metastatic enteropancreatic neuroendocrine tumors

Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms--Predictive and Prognostic Markers for Treatment Stratification

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.

Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.

Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience.

Outcomes of patients treated with capecitabine and temozolamide for advanced pancreatic neuroendocrine tumors (PNETs) and non-PNETs

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Everolimus for advanced pancreatic neuroendocrine tumors.

O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents

Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

P304

67-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000477800

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Gress

P577

2017-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28728148

http://www.w3.org/2001/XMLSchema#string

P921

cytotoxicity